Caribou Biosciences to Participate in Upcoming Investor Conferences
November 07, 2022 16:05 ET
|
Caribou Biosciences, Inc.
BERKELEY, Calif., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced the company’s...
Merus to Present at the Jefferies London Healthcare Conference
November 09, 2017 07:30 ET
|
Merus N.V.
UTRECHT, The Netherlands, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Merus N.V. (NASDAQ:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, today announced...